LATIGO BIOTHERAPEUTICS, INC.

Consensus Latigo Biotherapeutics, Inc.

Stocks

LTGO

US5179541033

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-11-06 EST			5-day change	1st Jan Change
12.60 ^USD	-3.15%		-9.68%	-

11-05	Latigo Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
09-20	Latigo Biotherapeutics, Inc.(NasdaqGS:LTGO) added to S&P TMI Index	CI

Evolution of the Average Target: Latigo Biotherapeutics, Inc.

Evolution of the Average Target - Latigo Biotherapeutics, Inc.

Evolution of the Target Price: Latigo Biotherapeutics, Inc.

Evolution of the Target Price - Latigo Biotherapeutics, Inc.

Changes in Analyst Recommendations: Latigo Biotherapeutics, Inc.

c76acc61aa0f6dc94af74b3f3ef6180.vuS6FyaILNQLc-SBuJ2yITfgGNyACRjZqFQ2Oh8EANQ.jtLOJRfyeaFxR4nv-cTRRG3Tb4j2PHSazC1TXW19ZZvuke9OSOQa4DI2iw~2507ba2a826b2fcc9b802ab17524addd

Analysts' recommendations: Latigo Biotherapeutics, Inc.

09-01	Jefferies Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Leerink Partners Initiates Latigo Biotherapeutics at Outperform With $36 Price Target	MT
09-01	Guggenheim Initiates Latigo Biotherapeutics at Buy With $50 Price Target	MT
09-01	Goldman Sachs Initiates Latigo Biotherapeutics at Buy With $73 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LATIGO BIOTHERAPEUTICS, INC.					+301.61%
	WUXI APPTEC CO., LTD.					+31%
	LONZA GROUP AG					+4.89%
	ARGENX SE					+22.4%
	BEONE MEDICINES AG					+12.99%
	IQVIA HOLDINGS INC.					+17.75%
	REVOLUTION MEDICINES, INC.					+45.7%
	CELLTRION, INC.					+27.37%
	GENMAB A/S					+10.13%
	WUXI BIOLOGICS (CAYMAN) INC.					+23.84%
	Average					+49.77%
	Weighted average by Cap.					+22.19%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

4

Last Close Price

12.60USD

Average target price

52.25USD

Spread / Average Target

+314.68%

High Price Target

73.00USD

Spread / Highest target

+479.37%

Low Price Target

36.00USD

Spread / Lowest Target

+185.71%

Analyst Consensus Detail

Analyst consensus - Latigo Biotherapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Latigo Biotherapeutics, Inc.

Stock Market
Stocks
LTGO Stock
Consensus Latigo Biotherapeutics, Inc.

As early as today, start finding the best investment opportunities!